Aviir Inks $10M
Aviir Inc., a biotechnology company focused on the prevention of cardiovascular disease, has raised $10 million in a new tranche of financing. Investors include Partners & Partners, Bay City Capital, Aberdare Ventures, and New Leaf Venture Partners.
12 February 2013•4 mins read
